Related by context. All words. (Click for frequent words.) 75 Zevalin 67 Treanda 67 Amrubicin 66 ofatumumab 66 VELCADE 66 FOLOTYN 66 indolent NHL 66 Fludara 66 Onco TCS 66 Marqibo 65 ZEVALIN ® 65 belinostat 65 Rituximab 64 FavId 64 FUSILEV 64 MGCD# [001] 64 panitumumab 64 BEXXAR 64 docetaxel Taxotere R 64 TYZEKA 63 TRISENOX 63 biologic therapy 63 RITUXAN 63 TORISEL 63 ONTAK 63 CHOP chemotherapy 63 Taxotere ® 63 brentuximab vedotin 63 follicular NHL 63 sBLA 63 AGGRASTAT ® 63 rituximab 63 TREANDA 63 MAA submission 62 ERBITUX 62 valopicitabine 62 Clolar 62 picoplatin 62 Vidaza 62 tanespimycin 62 AGGRASTAT R 62 ixabepilone 62 ALIMTA 62 YERVOY 62 TYKERB 62 Campath 62 HuMax CD4 62 sunitinib malate 62 Icatibant 62 metastatic CRC 62 HER2 positive metastatic breast 62 UPLYSO 62 Restanza 62 blinatumomab 62 bendamustine 62 Rituxan 62 OPAXIO 62 Neulasta ® 61 eniluracil 61 pegfilgrastim 61 relapsed refractory 61 satraplatin 61 HGS ETR1 61 Bortezomib 61 ibritumomab tiuxetan 61 celgosivir 61 MabCampath 61 CoFactor 61 Taxotere R 61 vinorelbine 61 Targretin 61 THALOMID 61 TELCYTA 61 Azedra 61 obatoclax 61 YONDELIS 61 Nexavar ® 61 Traficet EN 61 tamibarotene 61 Targretin capsules 61 Ventavis 61 T DM1 60 Clolar ® 60 lumiliximab 60 PROMACTA 60 alvimopan 60 ONCASPAR 60 Panzem R NCD 60 infusional 5-FU/LV 60 standard chemotherapy regimen 60 Ceplene 60 SPRYCEL 60 PXD# 60 ponatinib 60 Dacogen injection 60 Chemophase 60 perifosine 60 EFAPROXYN 60 Hycamtin 60 oral ridaforolimus 60 ISENTRESS 60 AP# [003] 60 enzastaurin 60 EOquin 60 L BLP# 60 Pixantrone 60 EOquin TM 60 tiuxetan 60 pralatrexate 60 CVP chemotherapy 60 ADVEXIN 60 lintuzumab 60 Tiuxetan 60 cutaneous T cell 60 forodesine 60 posaconazole 60 MNTX 60 ularitide 60 Gemzar ® 60 CYCLOSET 60 MyVax R 60 Velcade bortezomib 60 thymalfasin 60 metastatic colorectal cancer 60 Amigal 59 Leukine 59 Allovectin 7 59 IL# PE#QQR 59 registrational 59 SUTENT 59 trabectedin 59 pixantrone 59 Myocet 59 methylnaltrexone 59 ORENCIA R 59 ganetespib 59 palifosfamide 59 Aloxi 59 azacitidine 59 Vectibix 59 REVLIMID R 59 registrational trial 59 remission induction 59 ISTODAX 59 apaziquone 59 registrational studies 59 CAELYX 59 BiovaxID 59 AeroLEF TM 59 DOXIL 59 TYSABRI 59 Plenaxis R 59 relapsed multiple myeloma 59 ZOLINZA 59 Troxatyl 59 Cimzia ® 59 SinuNase 59 INCB# [002] 59 Satraplatin 59 Cladribine Tablets 59 Fludara ® 59 Keppra ® 59 dasatinib 59 Junovan 59 PROVIGIL 59 bazedoxifene 59 custirsen 59 alvespimycin 59 AzaSite Plus 59 Octreotide 59 follicular non 59 Cinryze TM 59 ezogabine 59 INTELENCE 59 dacarbazine 59 pemetrexed 59 Reclast Aclasta 59 TEMODAL 59 vandetanib 59 QUADRAMET 59 elotuzumab 59 Dacogen 59 Plenaxis TM 59 VIDAZA 58 ruxolitinib 58 Locteron 58 Aclasta 58 hematological cancers 58 Proxinium TM 58 Jevtana 58 LEUKINE 58 refractory Hodgkin lymphoma 58 relapsed refractory multiple myeloma 58 rilonacept 58 HUMIRA 58 telbivudine 58 IMGN# 58 carboplatin paclitaxel 58 bevacizumab Avastin ® 58 albinterferon alfa 2b 58 docetaxel Taxotere ® 58 ORENCIA ® 58 Carfilzomib 58 phase IIb clinical 58 romidepsin 58 lymphoma CTCL 58 B CLL 58 NUVIGIL 58 Personalized Immunotherapy 58 VPRIV 58 nimotuzumab 58 JAK inhibitor 58 Trastuzumab 58 CIMZIA TM 58 INCB# [001] 58 Kuvan 58 OMAPRO 58 BAY #-# 58 OvaRex R 58 Pemetrexed 58 Ozarelix 58 Zevalin R Ibritumomab 58 clofarabine 58 multiple myeloma MM 58 TYGACIL 58 NOXAFIL 58 abatacept 58 dose cohorts 58 Hycamtin ® 58 refractory APL 58 MEPACT 58 Pixuvri 58 imetelstat 58 Plicera 58 Ceflatonin 58 Irinotecan 58 ELACYT 58 Zerenex 58 Civacir 58 previously untreated follicular 58 confirmatory Phase III 58 SPRYCEL ® 58 atacicept 58 Cinryze 58 BENLYSTA 58 Telavancin 58 Zenvia ™ 58 Perifosine 58 AVINZA 58 Mylotarg 58 KALBITOR 58 glufosfamide 58 Cethrin 58 Campath ® 58 non metastatic osteosarcoma 58 Novantrone 58 CANCIDAS 58 Genasense 58 Revlimid lenalidomide 58 talactoferrin 58 NEBIDO 58 nilotinib 58 ARCALYST 58 xanthine oxidase inhibitor 58 TRISENOX R 57 BRIM2 57 carfilzomib 57 Alemtuzumab 57 relapsed refractory aggressive 57 aflibercept 57 pegloticase 57 phase IIb trial 57 FTY# 57 lorvotuzumab mertansine 57 OncoVEX GM CSF 57 Ofatumumab 57 REVLIMID 57 Tamibarotene 57 dextromethorphan quinidine 57 fidaxomicin 57 regadenoson 57 Infergen 57 Increlex R 57 Gleevec Glivec 57 docetaxel chemotherapy 57 HuMax CD# 57 receptor tyrosine kinase inhibitor 57 LEVAQUIN 57 MOZOBIL 57 Increlex ® 57 Folotyn 57 Cellegesic 57 Rebif ® 57 Certican 57 T Pred 57 ofatumumab HuMax CD# 57 KRN# 57 XL# XL# 57 MabThera Rituxan 57 rNAPc2 57 Evoltra ® 57 amrubicin 57 REMICADE ® 57 APTIVUS r 57 Pivotal Study 57 SIMPONI 57 AQ4N 57 PROVENGE 57 AVONEX 57 Elagolix 57 Camptosar ® 57 INTEGRILIN 57 rhThrombin 57 Evoltra 57 Ixempra 57 Tarceva TM 57 LymphoStat B 57 Arixtra 57 PhosLo 57 brentuximab vedotin SGN 57 pradefovir 57 cetuximab Erbitux R 57 cytotoxic chemotherapy 57 OZURDEX ® 57 deforolimus 57 Voraxaze ™ 57 Cimzia R 57 Vilazodone 57 Bezielle 57 IRESSA 57 Xcytrin R 57 Clofarabine 57 Belinostat 57 Xanafide 57 cell lymphoma CTCL 57 TELINTRA 57 sorafenib tablets 57 Arzerra ofatumumab 57 Firazyr 57 Allovectin 7 ® 57 INC# 57 Numax 57 HGS# 57 Loramyc ® 57 vorinostat 57 Erbitux cetuximab 57 Panitumumab 57 L MTP PE 57 PDX pralatrexate 57 Fibrin Pad 57 ridaforolimus 57 mifamurtide 57 ZYBRESTAT 57 decitabine 57 mapatumumab 57 Gliadel Wafer 57 BENLYSTA ® 57 HspE7 57 Mepact 57 vosaroxin 57 Phase III pivotal 57 SinuNase TM 57 MYLOTARG 57 CD# antibody [001] 57 Noxafil 57 Phase 1b trial 57 FIRAZYR 57 DORIBAX 57 PANVAC VF 57 bortezomib Velcade R 57 cSSSI 57 Specifid 57 Octreolin 57 MGd 57 SAPHRIS 57 veltuzumab 56 Prochymal 56 TRISENOX ® 56 Zelrix 56 pertuzumab 56 MAGE A3 ASCI 56 axitinib 56 SYCREST 56 TOCOSOL Paclitaxel 56 CIMZIA ™ 56 acyclovir Lauriad R 56 galiximab 56 IV Busulfex 56 trastuzumab DM1 T DM1 56 AMEVIVE 56 Extavia 56 Angiox 56 DIFICID 56 Combidex 56 TNFerade 56 Methylnaltrexone 56 low dose cytarabine 56 Gleevec imatinib mesylate 56 Tavocept 56 IMA# 56 metastatic renal cell carcinoma 56 RAPTIVA 56 PROVENGE ® 56 PREOS R 56 Navelbine ® 56 mRCC 56 AVASTIN 56 Fusilev 56 Eloxatin R 56 lesinurad 56 leucovorin 56 FOLOTYN ® 56 zalutumumab 56 Rituxan MabThera 56 cilengitide 56 BARACLUDE R 56 Aflibercept 56 Docetaxel 56 CR# vcMMAE 56 HCD# [002] 56 Torisel 56 oral methylnaltrexone 56 PEGINTRON 56 Tekamlo 56 investigational monoclonal antibody 56 Telaprevir 56 TAXOTERE R 56 Voreloxin 56 rALLy clinical trial 56 OvaRex ® MAb 56 Urocidin 56 Natalizumab 56 Exalgo 56 RELISTOR ® 56 RECOTHROM 56 subcutaneous formulation 56 neratinib 56 Zavesca R 56 superficial bladder cancer 56 FASLODEX 56 Catena ® 56 temozolomide 56 XYOTAX TM 56 PEG PAL 56 Advexin 56 NVA# 56 elacytarabine 56 Bicifadine 56 sipuleucel T 56 bevacizumab Avastin 56 romiplostim 56 Taxotere docetaxel 56 eculizumab 56 Epratuzumab 56 XL# [003] 56 Arzerra 56 Arcalyst 56 R sorafenib tablets 56 Loramyc R 56 tesmilifene 56 PRISTIQ 56 peginesatide 56 everolimus tablets 56 Ilaris 56 DAVANAT 56 maribavir 56 Oncaspar 56 BLA submission 56 sunitinib 56 nab paclitaxel 56 temsirolimus 56 Oncophage 56 CINTREDEKIN BESUDOTOX 56 Actimmune ® 56 docetaxel 56 hematologic malignancies 56 oral fludarabine 56 Tracleer R 56 HDAC Inhibitor 56 Xyrem ® 56 Kepivance 56 pivotal Phase III 56 PEG SN# 56 chlorambucil 56 Phase 2b study 56 ZYVOX 56 Omigard 56 interferon gamma 1b 56 teduglutide 56 Frova ® 56 retigabine 56 HCV protease inhibitor 56 FOLFIRI 56 topical NSAID 56 HRPC 56 rituximab Rituxan 56 Peginterferon alfa 2b 56 Raptiva R 56 Romidepsin 56 ELOXATIN 56 DexaSite 56 Exforge 56 gemcitabine Gemzar ® 56 MoxDuo IR 56 platinum refractory 56 chemotherapy regimens 56 RG# [001] 56 mitomycin 56 velafermin 56 Vaprisol 56 IMC A# 56 palifermin 56 sNDA submission 56 Copegus ribavirin 56 XYOTAX 55 Mozobil 55 Excellarate 55 Cetrorelix 55 sorafenib Nexavar 55 cutaneous T 55 TACI Ig 55 ABRAXANE 55 Pegasys peginterferon alfa 2a 55 sapacitabine 55 Abraxane 55 FACTIVE 55 TAFA# 55 Sebivo 55 Stedivaze 55 trastuzumab Herceptin R 55 Nimotuzumab 55 refractory PTCL 55 Virulizin R 55 histamine dihydrochloride 55 Leukine ® 55 Azedra TM 55 Phase 2a trial 55 Daclizumab 55 Anturol 55 Camptosar 55 Phase 2b clinical 55 HGS ETR2 55 Fibrillex TM 55 alefacept 55 Celgene Revlimid 55 febuxostat 55 Stimuvax R 55 Dasatinib 55 XGEVA 55 Cloretazine 55 Somatuline Depot 55 fludarabine 55 systemic ALCL 55 adalimumab 55 Revlimid 55 telaprevir VX 55 pomalidomide 55 liposomal formulation 55 HuMax EGFr 55 brivaracetam 55 taxane 55 BAL# [002] 55 EndoTAG TM -1 55 GSK# [001] 55 LEP ETU 55 paliperidone ER 55 huC# DM4 55 Emezine 55 unique alkylating agent 55 ARIKACE 55 chronic angina 55 HuLuc# 55 ALGRX 55 cetuximab 55 Saforis 55 MabThera 55 Zelapar 55 cetuximab Erbitux ® 55 Indaflex TM 55 oblimersen 55 refractory chronic lymphocytic 55 Ceftobiprole 55 StaphVAX 55 PRT# 55 investigational humanized monoclonal antibody 55 Onalta 55 PEGINTRON TM 55 evaluating tivozanib 55 BLA filing 55 Actimmune R 55 bafetinib 55 PSMA ADC 55 Neupogen ® 55 Strativa 55 REOLYSIN ® 55 UVIDEM 55 lymphoid malignancies 55 OFIRMEV 55 Aptivus ® 55 Raptiva ® 55 Dalbavancin 55 lenalidomide Revlimid R 55 ThermoDox ® 55 follicular lymphoma 55 SEBIVO 55 paclitaxel Taxol R 55 PREOS 55 Nexavar 55 AVONEX ® 55 Folfox 55 oral prodrug 55 immunotherapeutic agent 55 cancer immunotherapies 55 Relistor 55 DXL# 55 dacetuzumab 55 dirucotide 55 Pivotal Phase 55 OMP designation 55 OHR/AVR# 55 teriflunomide 55 glatiramer acetate 55 ozarelix 55 palonosetron 55 Bevacizumab 55 Microplasmin 55 Diabetic Macular Edema 55 anti TNF alpha 55 cell chronic lymphocytic 55 GATTEX 55 Multikine 55 Rituxan rituximab 55 thetreatment 55 Aclasta Reclast 55 ceftaroline 55 vemurafenib 55 cetuximab Erbitux 55 pegylated interferon alpha 55 SCCHN 55 antithrombotics 55 bosutinib 55 severe hypercholesterolemia 55 BCR ABL inhibitor 55 ciclesonide 55 Gemcitabine 55 histone deacetylase HDAC inhibitor 55 hoFH 55 Orphan Drug designations 55 placebo controlled Phase III 55 Imprime PGG 55 fipamezole 55 XmAb# 55 relapsed SCLC 55 LEVADEX ™ 55 bortezomib Velcade 55 MultiStem 55 Brentuximab Vedotin SGN 55 PNP inhibitor 55 reslizumab 55 cinacalcet 55 BrachySil TM 55 Vasovist 55 Herceptin trastuzumab 55 Platinol 55 KNS # 55 bicifadine 55 Cloretazine ® 55 ustekinumab 55 BROVANA 55 Phenoptin 55 Oxaliplatin 55 TBC# 55 prGCD 55 PDE4 inhibitor 55 GEMZAR 55 dalbavancin 55 ospemifene 55 plus prednisone 55 SNT MC# 55 ANTEGREN 55 natalizumab 55 Pradefovir 55 pirfenidone 55 novel histone deacetylase 55 Pertuzumab 55 pexelizumab 55 Onsolis 55 Tarceva erlotinib 55 RELISTOR 55 cangrelor 55 Alvesco R 55 orphan medicinal product 55 RAPAFLO 55 Vectibix panitumumab 55 Alocrest 55 Aryplase 55 PLK1 SNALP 55 relapsing multiple sclerosis 55 FOLFOX regimen 55 Betaferon ® 55 pseudobulbar affect PBA 55 tivozanib 55 voreloxin 55 Tygacil 55 herpetic keratitis 55 PEG Interferon lambda 55 AEGR 55 rasagiline tablets 55 ABRAXANE ® 55 monotherapy 55 Ketotransdel 55 daclizumab 55 ZADAXIN 55 erlotinib Tarceva ® 55 dasatinib Sprycel 55 Entereg R 55 assessing T DM1 55 PI3K/Akt pathway inhibitor 54 chronic lymphocytic leukemia CLL 54 Evoltra TM 54 ZENPEP 54 Cetuximab Erbitux 54 Augment Injectable 54 dasatinib Sprycel ® 54 5 Fluorouracil 54 Anthim 54 Soliris eculizumab 54 Cloretazine R VNP#M 54 ABILIFY R 54 Temsirolimus 54 Neurodex 54 ZEGERID Capsules 54 gefitinib Iressa 54 Metastatic Colorectal Cancer 54 REBETOL combination therapy 54 dimebon 54 tasocitinib 54 gemcitabine 54 Viramidine 54 XL# XL# XL# 54 5 FU 54 panitumumab Vectibix 54 OncoVEX 54 Phase III Trial 54 IV APAP 54 INTEGRILIN ® 54 paclitaxel Taxol 54 supplemental biologics 54 Cladribine 54 mipomersen 54 Nuvion 54 ZADAXIN ® 54 epratuzumab 54 Pimavanserin 54 YONDELIS R 54 Cethromycin 54 ATryn R 54 Azixa 54 REVLIMID ® 54 GATTEX TM 54 Rhucin 54 ALN TTR# 54 ACTEMRA TM 54 Tesetaxel 54 Ambrisentan 54 Evoltra R 54 myelofibrosis 54 Xcellerated T Cells 54 oritavancin 54 Reverset 54 Targeted Chemotherapy 54 lapatinib 54 Acetavance 54 tesetaxel 54 methylnaltrexone bromide 54 adecatumumab 54 liposomal doxorubicin 54 INT# [002] 54 Phase 1b 54 velaglucerase alfa 54 tyrosine kinase inhibitor 54 indacaterol 54 ARIXTRA 54 SAR# [004] 54 VAPRISOL 54 efalizumab 54 Pegasys ® 54 phase IIa clinical 54 Glufosfamide 54 Phase Ib 54 NATRECOR R 54 Pivotal Trial 54 Vandetanib 54 orally administered inhibitor 54 rALLy 54 baminercept 54 Aurexis 54 adalimumab Humira 54 REYATAZ R 54 Romiplostim 54 HQK 54 Tasigna nilotinib 54 anakinra 54 anidulafungin 54 edoxaban 54 DCVax R Brain 54 bortezomib 54 Azedra ™ 54 tezampanel 54 COMFORT II 54 alemtuzumab 54 Phase #b/#a clinical 54 IRX 2 54 Aloxi R 54 Lenalidomide 54 oral anticoagulant 54 heavily pretreated 54 Filgrastim 54 Carboplatin 54 ENBREL 54 Tekturna HCT 54 faropenem 54 Erbitux 54 Arsenic trioxide 54 XIAFLEX 54 humanized anti 54 Xeloda ® 54 voclosporin 54 Tanespimycin 54 Fodosine 54 Sandostatin LAR 54 Golimumab 54 Etanercept 54 alpha 2a 54 NSCLC 54 rituximab refractory 54 tigecycline 54 ® natalizumab 54 COPAXONE ® 54 systemic anaplastic large 54 docetaxel Taxotere 54 goserelin 54 oxaliplatin 54 Pegintron 54 dose escalation 54 JANUVIA 54 plus DOXIL 54 Entereg 54 pediatric acute lymphoblastic 54 danoprevir 54 octreotide implant 54 XIFAXAN 54 PEP# [003] 54 leading oral taxane 54 radiation sensitizer 54 NPSP# 54 Tasigna 54 Oracea ® 54 ALN TTR 54 Cimzia ® certolizumab pegol 54 BRAF inhibitor 54 MYCAMINE 54 BCX# 54 Phase Ib study 54 relapsing MS 54 IIa trial 54 balsalazide tablet 54 regorafenib 54 sNDA 54 Rhucin ® 54 NeuroStar TMS Therapy 54 Sprycel 54 Ixabepilone 54 OXi# 54 Talabostat 54 CYT# 54 Vimpat ® 54 StemEx 54 Pivotal Phase III 54 imatinib mesylate 54 tolevamer 54 Reolysin 54 rindopepimut 54 orphan designation 54 pan HDAC inhibitor 54 vicriviroc 54 relapsed MM 54 Azilect ® 54 Archexin 54 Zingo TM 54 ASA# 54 HP Acthar Gel repository 54 relapsed CLL 54 Zavesca ® miglustat 54 KRAS mutations occur 54 Fampridine SR 54 gemcitabine Gemzar 54 irinotecan 54 ENDEAVOR IV 54 tafamidis 54 elvucitabine 54 gastrointestinal stromal tumors GIST 54 Dapagliflozin 54 taliglucerase alfa 54 calcineurin inhibitors 54 Solazed 54 milatuzumab 54 DAVANAT R 54 ribavirin RBV 54 LIALDA 54 Nebido 54 EGFR TKI 54 cyclophosphamide doxorubicin vincristine 54 Rebif R 54 gefitinib 54 Viprinex 54 AZILECT ® 54 ZACTIMA 54 Hepatocellular Carcinoma HCC 54 icatibant 54 PREZISTA r 54 Rhucin R 54 elagolix 54 Privigen 54 VICTRELIS 54 fingolimod 54 Fludarabine 54 sargramostim 54 chemotherapeutic regimen 54 Avastin bevacizumab 54 Doxil 54 #D#C# 54 DMARD 54 carboplatin 54 ProLindac 54 thalidomide Thalomid 54 relapsing remitting multiple sclerosis 54 torezolid phosphate 54 NEUPOGEN 54 PEGylated interferon beta 1a 54 WelChol 54 amifampridine phosphate 54 Phase 2b trial 54 CVP cyclophosphamide vincristine 54 etoposide 54 Cimzia TM 54 APTIVUS 54 Mitoxantrone 54 REVLIMID lenalidomide 54 infliximab 54 Removab 54 dose cohort 54 Trofex TM 54 CD3 monoclonal antibody 54 fenofibrate 54 gemcitabine chemotherapy 54 INCB# [003] 54 VALSTAR 54 concurrent chemoradiation 54 ONGLYZA ™ 54 CIMZIA 54 Lenocta 54 daptomycin 54 VFEND 54 IXEMPRA 54 Argatroban 54 Sutent sunitinib 54 ENRICH trial 54 postoperative ileus POI 54 REBETOL 54 Besivance 54 KRYSTEXXA 54 Denosumab 54 intravesical infusion therapy 54 Multaq R 54 visilizumab 54 PrevOnco 54 candidate AQ4N 54 AEG# 54 omacetaxine mepesuccinate 54 phase IIb 54 PS# [001] 54 etanercept Enbrel 54 Afinitor ® 54 Pazopanib 54 non squamous NSCLC 54 MERLIN TIMI 53 RAPTIVA R 53 refractory metastatic colorectal cancer 53 PROSTVAC TM 53 oxymorphone ER 53 Phase #/#a 53 Ceflatonin R 53 REMICADE infliximab 53 phase Ib 53 Hyphanox 53 allogeneic stem cell 53 OLEPTRO TM 53 Soliris TM eculizumab